These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2787895)

  • 61. AIDS two months after primary human immunodeficiency virus infection.
    Isaksson B; Albert J; Chiodi F; Furucrona A; Krook A; Putkonen P
    J Infect Dis; 1988 Oct; 158(4):866-8. PubMed ID: 3171228
    [No Abstract]   [Full Text] [Related]  

  • 62. Induction of autoantibodies by human immunodeficiency virus infection and their significance.
    Solinger AM; Hess EV
    Rheum Dis Clin North Am; 1991 Feb; 17(1):157-76. PubMed ID: 2041885
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Current status of the development of an AIDS vaccine.
    Lasky LA
    Crit Rev Immunol; 1989; 9(3):153-72. PubMed ID: 2673294
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Specific antibody and virus antigen expression in congenital HIV infection.
    Tovo PA; Gabiano C; Riva C; Palomba E; Valpreda A; Musso A
    Lancet; 1987 May; 1(8543):1201. PubMed ID: 2883510
    [No Abstract]   [Full Text] [Related]  

  • 65. The CD4 receptor for the AIDS virus.
    Weiss RA; Clapham PR; McClure M; Marsh M
    Biochem Soc Trans; 1989 Aug; 17(4):644-7. PubMed ID: 2475372
    [No Abstract]   [Full Text] [Related]  

  • 66. Protective immunity against HIV infection: lessons from HIV-2 infection.
    Rowland-Jones S
    Future Microbiol; 2006 Dec; 1(4):427-33. PubMed ID: 17661633
    [TBL] [Abstract][Full Text] [Related]  

  • 67. AIDS vaccine predictions.
    Barin F
    Nature; 1987 Jul 2-8; 328(6125):21. PubMed ID: 3474526
    [No Abstract]   [Full Text] [Related]  

  • 68. [Diagnosis and the methods of evaluating the degree of impairment of the immune system in HIV infection].
    Radkowski M; Laskus T
    Pol Arch Med Wewn; 1992 Jun; 87(6):372-8. PubMed ID: 1357632
    [No Abstract]   [Full Text] [Related]  

  • 69. Antibodies mediating cellular cytotoxicity and neutralization correlate with a better clinical stage in children born to human immunodeficiency virus-infected mothers.
    Ljunggren K; Moschese V; Broliden PA; Giaquinto C; Quinti I; Fenyö EM; Wahren B; Rossi P; Jondal M
    J Infect Dis; 1990 Feb; 161(2):198-202. PubMed ID: 2299204
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [AIDS vaccines: an enigma in vaccine development].
    Dorner F; Barrett N
    Wien Klin Wochenschr; 1990 Jan; 102(2):51-8. PubMed ID: 1689919
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Modern vaccines. Human immunodeficiency virus and AIDS: challenges and progress.
    Schild GC; Minor PD
    Lancet; 1990 May; 335(8697):1081-4. PubMed ID: 1970381
    [No Abstract]   [Full Text] [Related]  

  • 72. Antibody-dependent cellular cytotoxicity (ADCC)-mediated destruction of human immunodeficiency virus (HIV)-coated CD4+ T lymphocytes by acquired immunodeficiency syndrome (AIDS) effector cells.
    Katz JD; Nishanian P; Mitsuyasu R; Bonavida B
    J Clin Immunol; 1988 Nov; 8(6):453-8. PubMed ID: 2975670
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Anti-cellular antibodies in sera from vaccinated macaques can induce complement-mediated virolysis of human immunodeficiency virus and simian immunodeficiency virus.
    Spear GT; Takefman DM; Sullivan BL; Landay AL; Jennings MB; Carlson JR
    Virology; 1993 Aug; 195(2):475-80. PubMed ID: 8337824
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Designing CD4 immunoadhesins for AIDS therapy.
    Capon DJ; Chamow SM; Mordenti J; Marsters SA; Gregory T; Mitsuya H; Byrn RA; Lucas C; Wurm FM; Groopman JE
    Nature; 1989 Feb; 337(6207):525-31. PubMed ID: 2536900
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Affinity of anti-HIV antibodies in patients with asymptomatic and symptomatic HIV infection].
    Radkowski M; Laskus T; Goch A; Babiuch L; Slusarczyk J
    Przegl Epidemiol; 1991; 45(4):369-72. PubMed ID: 1841418
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Immunology of AIDS.
    Heiss R
    Pediatr Ann; 1987 Jun; 16(6):495, 499, 502-6. PubMed ID: 2956567
    [No Abstract]   [Full Text] [Related]  

  • 77. Immunology. Bound for glory.
    Cohen J
    Science; 2013 Sep; 341(6151):1168-71. PubMed ID: 24030996
    [No Abstract]   [Full Text] [Related]  

  • 78. HIV-1MN recombinant gp120 vaccine serum, which fails to neutralize primary isolates of HIV-1, does not antagonize neutralization by antibodies from infected individuals.
    Wrin T; Nunberg JH
    AIDS; 1994 Nov; 8(11):1622-3. PubMed ID: 7848602
    [No Abstract]   [Full Text] [Related]  

  • 79. What are the correlates of protection?
    Cohen J
    Science; 1993 May; 260(5112):1259. PubMed ID: 8493565
    [No Abstract]   [Full Text] [Related]  

  • 80. Delayed appearance of HIV infection in children.
    Aiuti F; Luzi G; Mezzaroma I; Scano G; Papetti C
    Lancet; 1987 Oct; 2(8563):858. PubMed ID: 2889059
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.